During the past decade, Boyett Health Services conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boyett Health Services" #1 collaborator was "Camurus AB" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Boyett Health Services" are "Opioid Use Disorder" (3 trials), "Opioid-related Disorders" (3 trials), "Cardiovascular Disease" (2 trials), "Severe Hypertriglyceridemia" (2 trials) and "Chronic Lower Back Pain" (1 trials). Many other conditions were trialed in "Boyett Health Services" in a lesser frequency.

Most popular intervention types in "Boyett Health Services" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "RBP-6000" (3 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Boyett Health Services" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Boyett Health Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Boyett Health Services, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Boyett Health Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".